August 8th, 2025: Novo Nordisk Expands Trademark Actions Against Compounded Ozempic Sellers Novo Nordisk has escalated its efforts to protect the Ozempic trademark, filing 14 new federal lawsuits against pharmacies, telehealth providers, and other sellers offering compounded semaglutide products
P., Deenadayalan, S., Erichsen, L., et al
Women of childbearing potential should use effective contraception during treatment
Using one 60 mg vial instead of six 10 mg vials means fewer supply purchases and less waste
This means even in states like Pennsylvania that eliminated adult obesity GLP-1 coverage, children under 21 may still qualify
How Do I Appeal an Anthem GLP-1 Denial